A high level of peripheral NGF has been shown to be associated with ovarian and breast cancer, polycystic ovarian syndrome (PCOS), and endometriosis [57, 58], providing evidence for the increased risk of breast and endometrial cancer caused by long-term estrogen replacement therapy [59, 60]. The gene discussed is NGF; the disease is polycystic ovary syndrome.